Survival and prognostic factors after initiation of treatment in Waldenstrom's macroglobulinemia.
Dimopoulos MA, Hamilos G, Zervas K, Symeonidis A, Kouvatseas G, Roussou P, Gika D, Karmiris T, Bourantas K, Zomas A, Mitsouli C, Xilouri I, Vervessou E, Matsis K, Anagnostopoulos N, Economopoulos T; Greek Myeloma Study Group.
Dimopoulos MA, et al. Among authors: hamilos g.
Ann Oncol. 2003 Aug;14(8):1299-305. doi: 10.1093/annonc/mdg334.
Ann Oncol. 2003.
PMID: 12881396
Free article.